KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $411.8 million.

  • Fulgent Genetics' Long-Term Investments fell 3162.47% to $411.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.8 million, marking a year-over-year decrease of 3162.47%. This contributed to the annual value of $570.4 million for FY2024, which is 3465.3% up from last year.
  • As of Q3 2025, Fulgent Genetics' Long-Term Investments stood at $411.8 million, which was down 3162.47% from $484.5 million recorded in Q2 2025.
  • Fulgent Genetics' Long-Term Investments' 5-year high stood at $602.2 million during Q3 2024, with a 5-year trough of $287.6 million in Q1 2021.
  • For the 5-year period, Fulgent Genetics' Long-Term Investments averaged around $439.4 million, with its median value being $415.6 million (2022).
  • Per our database at Business Quant, Fulgent Genetics' Long-Term Investments soared by 130273.46% in 2021 and then crashed by 3265.64% in 2022.
  • Quarter analysis of 5 years shows Fulgent Genetics' Long-Term Investments stood at $485.0 million in 2021, then plummeted by 32.66% to $326.6 million in 2022, then grew by 29.67% to $423.6 million in 2023, then skyrocketed by 34.65% to $570.4 million in 2024, then decreased by 27.8% to $411.8 million in 2025.
  • Its last three reported values are $411.8 million in Q3 2025, $484.5 million for Q2 2025, and $494.1 million during Q1 2025.